LOW GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested in fight against recurrent ovarian cancer
Disease control OngoingThis study is testing the safety and effectiveness of a two-drug combination (avutometinib and defactinib) for Japanese patients with recurrent low-grade ovarian cancer. The goal is to see if this treatment can shrink tumors and control the disease. It is for patients whose cance…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new drug duo in fight against tough cancers
Disease control OngoingThis early-stage trial is testing the safety and best dose of a new two-drug combination for people with advanced solid tumors that have stopped responding to standard treatments. The study is focusing on specific cancers, including certain types of lung, ovarian, and pancreatic …
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC